The analysis of data from the TCGA database showed that the prognosis of patients with a high expression of FTO was worse (p = 0.0015; Figure 9G), and FTO expression was higher in patients with a high stage of bladder cancer (Figure 9H). This evidence concerns the gene FTO and urinary bladder cancer.